Annual D&A
$123.42 M
+$56.22 M+83.67%
31 December 2023
Summary:
Evolent Health annual depreciation & amortization is currently $123.42 million, with the most recent change of +$56.22 million (+83.67%) on 31 December 2023. During the last 3 years, it has risen by +$63.38 million (+105.56%). EVH annual D&A is now at all-time high.EVH Depreciation And Amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly D&A
$29.70 M
-$169.00 K-0.57%
30 September 2024
Summary:
Evolent Health quarterly depreciation & amortization is currently $29.70 million, with the most recent change of -$169.00 thousand (-0.57%) on 30 September 2024. Over the past year, it has increased by +$99.00 thousand (+0.33%). EVH quarterly D&A is now -8.34% below its all-time high of $32.40 million, reached on 30 September 2023.EVH Quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM D&A
$118.68 M
-$2.70 M-2.23%
30 September 2024
Summary:
Evolent Health TTM depreciation & amortization is currently $118.68 million, with the most recent change of -$2.70 million (-2.23%) on 30 September 2024. Over the past year, it has dropped by -$4.74 million (-3.84%). EVH TTM D&A is now -4.02% below its all-time high of $123.64 million, reached on 31 March 2024.EVH TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
EVH Depreciation And Amortization Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | - | +0.3% | -3.8% |
3 y3 years | +105.6% | +99.1% | +97.7% |
5 y5 years | +102.6% | +86.3% | +94.8% |
EVH Depreciation And Amortization High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3 years | at high | +105.6% | -8.3% | +99.1% | -4.0% | +98.5% |
5 y | 5 years | at high | +105.6% | -8.3% | +102.1% | -4.0% | +98.5% |
alltime | all time | at high | -8.3% | +4627.6% | -4.0% | >+9999.0% |
Evolent Health Depreciation And Amortization History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sept 2024 | - | $29.70 M(-0.6%) | $118.68 M(-2.2%) |
June 2024 | - | $29.87 M(+1.2%) | $121.38 M(-1.8%) |
Mar 2024 | - | $29.50 M(-0.3%) | $123.64 M(+0.2%) |
Dec 2023 | $123.42 M(+83.7%) | $29.60 M(-8.6%) | $123.42 M(+8.6%) |
Sept 2023 | - | $32.40 M(+0.8%) | $113.59 M(+15.5%) |
June 2023 | - | $32.13 M(+9.8%) | $98.39 M(+20.9%) |
Mar 2023 | - | $29.27 M(+48.0%) | $81.36 M(+21.1%) |
Dec 2022 | $67.19 M(+11.9%) | $19.78 M(+15.0%) | $67.19 M(+7.8%) |
Sept 2022 | - | $17.20 M(+13.8%) | $62.33 M(+3.9%) |
June 2022 | - | $15.11 M(+0.0%) | $59.99 M(+0.3%) |
Mar 2022 | - | $15.11 M(+1.3%) | $59.80 M(-0.4%) |
Dec 2021 | $60.04 M(-2.3%) | $14.91 M(+0.4%) | $60.04 M(+0.1%) |
Sept 2021 | - | $14.86 M(-0.4%) | $59.99 M(+0.3%) |
June 2021 | - | $14.92 M(-2.8%) | $59.82 M(-1.4%) |
Mar 2021 | - | $15.35 M(+3.2%) | $60.68 M(-1.3%) |
Dec 2020 | $61.48 M(+0.9%) | $14.87 M(+1.2%) | $61.48 M(-1.7%) |
Sept 2020 | - | $14.69 M(-6.9%) | $62.56 M(-1.1%) |
June 2020 | - | $15.78 M(-2.2%) | $63.27 M(+0.8%) |
Mar 2020 | - | $16.14 M(+1.2%) | $62.78 M(+3.1%) |
Dec 2019 | $60.91 M | $15.95 M(+3.5%) | $60.91 M(+2.2%) |
Sept 2019 | - | $15.41 M(+0.8%) | $59.60 M(+9.3%) |
June 2019 | - | $15.29 M(+7.2%) | $54.54 M(+10.7%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Mar 2019 | - | $14.27 M(-2.5%) | $49.28 M(+10.7%) |
Dec 2018 | $44.52 M(+37.5%) | $14.63 M(+41.4%) | $44.52 M(+8.5%) |
Sept 2018 | - | $10.35 M(+3.2%) | $41.01 M(+6.9%) |
June 2018 | - | $10.03 M(+5.7%) | $38.38 M(+8.9%) |
Mar 2018 | - | $9.50 M(-14.7%) | $35.25 M(+8.9%) |
Dec 2017 | $32.37 M(+87.9%) | $11.13 M(+44.3%) | $32.37 M(+16.7%) |
Sept 2017 | - | $7.72 M(+11.8%) | $27.73 M(+16.7%) |
June 2017 | - | $6.90 M(+4.4%) | $23.76 M(+16.1%) |
Mar 2017 | - | $6.62 M(+1.8%) | $20.47 M(+18.8%) |
Dec 2016 | $17.22 M(+140.4%) | $6.50 M(+73.5%) | $17.22 M(+24.3%) |
Sept 2016 | - | $3.75 M(+3.7%) | $13.85 M(+5.2%) |
June 2016 | - | $3.61 M(+7.1%) | $13.16 M(+24.9%) |
Mar 2016 | - | $3.37 M(+7.8%) | $10.54 M(+47.0%) |
Dec 2015 | $7.17 M(>+9900.0%) | $3.13 M(+2.3%) | $7.17 M(+77.4%) |
Sept 2015 | - | $3.06 M(+210.6%) | $4.04 M(+310.6%) |
June 2015 | - | $984.00 K(>+9900.0%) | $984.00 K(-250.0%) |
Mar 2015 | - | $0.00(0.0%) | -$656.00 K(<-9900.0%) |
Dec 2014 | $0.00(-100.0%) | $0.00(0.0%) | $0.00(0.0%) |
Sept 2014 | - | $0.00(-100.0%) | $0.00(0.0%) |
June 2014 | - | -$656.00 K(-200.0%) | $0.00(-100.0%) |
Mar 2014 | - | $656.00 K | $656.00 K |
Dec 2013 | $1.21 M | - | - |
FAQ
- What is Evolent Health annual depreciation & amortization?
- What is the all time high annual D&A for Evolent Health?
- What is Evolent Health quarterly depreciation & amortization?
- What is the all time high quarterly D&A for Evolent Health?
- What is Evolent Health quarterly D&A year-on-year change?
- What is Evolent Health TTM depreciation & amortization?
- What is the all time high TTM D&A for Evolent Health?
- What is Evolent Health TTM D&A year-on-year change?
What is Evolent Health annual depreciation & amortization?
The current annual D&A of EVH is $123.42 M
What is the all time high annual D&A for Evolent Health?
Evolent Health all-time high annual depreciation & amortization is $123.42 M
What is Evolent Health quarterly depreciation & amortization?
The current quarterly D&A of EVH is $29.70 M
What is the all time high quarterly D&A for Evolent Health?
Evolent Health all-time high quarterly depreciation & amortization is $32.40 M
What is Evolent Health quarterly D&A year-on-year change?
Over the past year, EVH quarterly depreciation & amortization has changed by +$99.00 K (+0.33%)
What is Evolent Health TTM depreciation & amortization?
The current TTM D&A of EVH is $118.68 M
What is the all time high TTM D&A for Evolent Health?
Evolent Health all-time high TTM depreciation & amortization is $123.64 M
What is Evolent Health TTM D&A year-on-year change?
Over the past year, EVH TTM depreciation & amortization has changed by -$4.74 M (-3.84%)